Aurora Cannabis ACB shares are trading higher on Tuesday in anticipation of the company's fourth-quarter earnings results, which are scheduled after the close today.
On Monday, Jefferies upgraded Aurora from Underperform to Hold and cut his price target from $10.51 to $6.53.
See Also: Jefferies Upgrades Aurora And Tilray, Says Valuations, Estimates 'Now More Realistic'
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis shares were trading up 17% at $7.40 on Tuesday at the time of publication. The stock has a 52-week high of $62.88 and a 52-week low of $5.30.
Update: Aurora Cannabis Stock Plunges 18% After Q4 Earnings Call
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.